BioMarket Group - Netherlands

Product Categories

Biotechnology Business Development Chemicals Country Argentina Australia Austria Bahrain Bangladesh Belarus Belgium Brazil Bulgaria Canada Chile China Colombia Costa Rica Croatia Cuba Czech Republic Denmark Estonia Europe Finland France Germany Greece Hong Kong Hungary India Indonesia Iran Ireland Israel Italy Japan Kuwait Latvia Lithuania Malaysia Mexico Morocco Netherlands New Zealand North America Oman Pakistan Peru Philippines Poland Portugal Romania Russia Saudi Arabia Serbia Singapore Slovakia Slovenia South Africa South Korea Spain Sweden Syria Taiwan Thailand Turkey Ukraine United Arab Emirates United Kingdom USA Venezuela Vietnam Egypt Jordan Switzerland Norway Malta Phillippines Diagnostics Drug Delivery Drug Discovery Drugs Finance & Investment Generic Drugs Healthcare IT & eHealth Management Marketing & Sales Medical Devices Production Publication Series R&D Regulation & Policy Therapeutics Veterinary

List All Products
Product Search Advanced Search

Login Form

Home

Country

Netherlands

Info: Your browser does not accept cookies. If you want to put products into your cart and purchase them you need to enable cookies.

Browse

Pharmaceuticals in the Netherlands

Pharmaceuticals in the Netherlands industry profile is an essential resource for top-level data and analysis covering the pharmaceuticals industry.

$250.00 Product Details...

OTC Pharmaceuticals in the Netherlands

OTC Pharmaceuticals in the Netherlands industry profile is an essential resource for top-level data and analysis covering the otc pharmaceuticals industry.

$250.00 Product Details...

Latest News

Expert Views: Key decision makers will shape the biosimilars landscape
Read more...

Expert Views: Is there an alternative to HRT for menopausal relief?
Read more...

Market Research Update W45 2008
Read more...

Latest Products

Stakeholder Opinions: Diabetic Renal Disease	Pipeline Insight: Orphan Diseases Myasthenia Gravis
Financial Deals Industry Tracker: Pharma & Healthcare Sep-2008	Sales Force Effectiveness
Forecast Model: Antidyslipidemics	Financial Deals Industry Tracker: Pharma & Healthcare Aug 2008
Stakeholder Insight: Osteoporosis	Pipeline and Commercial Insight: Schizophrenia
Emerging Markets Series: The Pharma Market of South Korea	Merck KGaA: PharmaVitae Profile
Les Laboratoires Servier: PharmaVitae Profile	Solvay S.A.: PharmaVitae Profile
Biogen Idec Inc.: PharmaVitae Profile	Strategic Perspectives: Antidyslipidemics Current market...
M&A trends in Pharma	Commercial Insight: Pain Market Overview
Sepracor Inc.: PharmaVitae Profile	RNA therapy: the next big thing after monoclonal antibodies?
The Top Ten Specialty Pharmaceutical Companies	The Promotional Landscape in US and Europe